Memantine Is Protective against Cytotoxicity Caused by Lead and Quinolinic Acid in Cultured Rat Embryonic Hippocampal Cells.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory research on animal cells
PubMed 30950269 · doi:10.1021/acs.chemrestox.8b00421
What was done
Primary hippocampal cell cultures from embryonic Wistar rats were treated with various concentrations of lead (Pb), quinolinic acid (QA), and combined Pb + QA, with or without the NMDA receptor antagonist memantine (500 nM). Cell viability was evaluated using the MTT assay, apoptosis was measured using Annexin-V/propidium iodide flow cytometry, and neuron and astrocyte counts were quantified using β3-Tubulin (Tuj1) and glial fibrillary acidic protein (GFAP) immunostaining, respectively.
What was found
Pb at 20 μg/dL (0.97 μM) and QA at 500 nM significantly decreased cell viability, increased apoptosis, and reduced counts of both neurons and astrocytes. Co-exposure to Pb and QA induced synergistic apoptotic effects at lower doses. Memantine (500 nM) largely attenuated the cytotoxic effects of both Pb and QA. Specific effect sizes, percentages, and variance figures were not reported in the abstract.
Why it matters
This study provides mechanistic evidence that lead neurotoxicity may involve NMDA receptor activation and can act synergistically with quinolinic acid, suggesting memantine as a candidate for future in vivo research.
Limits
The study was conducted entirely in vitro using embryonic rat hippocampal cultures, which do not capture complex systemic pharmacokinetics or blood-brain barrier dynamics. Exact numerical values for cell survival, apoptosis rates, and biological replicate numbers were not reported in the abstract.
Cited by
- supports Quinolinic acid exerts excitotoxic effects at the NMDA receptor.